{"id":1552,"date":"2017-07-26T12:52:08","date_gmt":"2017-07-26T12:52:08","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/?p=1552"},"modified":"2017-07-26T12:52:08","modified_gmt":"2017-07-26T12:52:08","slug":"enyo-pharma-poursuit-sa-strategie-a-linternational-et-ouvre-une-filiale-en-australie","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/enyo-pharma-poursuit-sa-strategie-a-linternational-et-ouvre-une-filiale-en-australie\/","title":{"rendered":"Â鶹Æƽâ°æ poursuit sa strat\u00e9gie \u00e0 l\u2019international et ouvre une filiale en Australie"},"content":{"rendered":"<p>Â鶹Æƽâ°æ a ouvert sa premi\u00e8re filiale en Australie. Ce bureau sera notre nouveau centre de gestion des essais cliniques dans la r\u00e9gion Asie-Pacifique. Â鶹Æƽâ°æ base son innovation en imitant les strat\u00e9gies de virus pour d\u00e9couvrir de nouvelles cibles cellulaires et d\u00e9velopper des candidats m\u00e9dicaments dans les maladies infectieuses ainsi que dans d\u2019autres indications.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Â鶹Æƽâ°æ a ouvert sa premi\u00e8re filiale en Australie. Ce bureau sera notre nouveau centre de gestion des essais cliniques dans la r\u00e9gion Asie-Pacifique. Â鶹Æƽâ°æ base son innovation en imitant les strat\u00e9gies de virus pour d\u00e9couvrir de nouvelles cibles cellulaires et d\u00e9velopper des candidats m\u00e9dicaments dans les maladies infectieuses ainsi que dans d\u2019autres indications.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/www.enyopharma.com\/fr\/enyo-pharma-poursuit-sa-strategie-a-linternational-et-ouvre-une-filiale-en-australie\/\">Lire la suite&nbsp;&raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-1552","post","type-post","status-publish","format-standard","hentry","category-latest-news-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/latest-news-fr\/\" rel=\"category tag\">Br\u00e8ves<\/a>","rttpg_excerpt":"Â鶹Æƽâ°æ a ouvert sa premi\u00e8re filiale en Australie. Ce bureau sera notre nouveau centre de gestion des essais cliniques dans la r\u00e9gion Asie-Pacifique. Â鶹Æƽâ°æ base son innovation en imitant les strat\u00e9gies de virus pour d\u00e9couvrir de nouvelles cibles cellulaires et d\u00e9velopper des candidats m\u00e9dicaments dans les maladies infectieuses ainsi que dans d\u2019autres indications.Lire&hellip;","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/1552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=1552"}],"version-history":[{"count":1,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/1552\/revisions"}],"predecessor-version":[{"id":1553,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/1552\/revisions\/1553"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=1552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=1552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=1552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}